Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
VIP
Batch #
N/A
Formula
C147H238N44O42S
Mol Wt
3326.8 g/mol
CAS
37221-79-7
Latest
ISO 17025
8× Testing
99.5%
Purity
VariantVIP
COA ##13129
Labeled10mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.5%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - VIP
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
The immunomodulatory potential of vasoactive intestinal peptide
02
Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
03
Vasoactive intestinal peptide and pulmonary arterial hypertension
04
VIP and PACAP in neurodegeneration and neuroprotection
05
Vasoactive intestinal peptide and COVID-19 pathogenesis: a promising therapeutic target
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
